Enobia Pharma Headquarters

Searching for Enobia Pharma Headquarters info? You have come to exactly the right place. We collected all data about Enobia Pharma Headquarters.

Enobia Pharma LinkedIn

https://www.linkedin.com/company/enobia-pharma

Locations. Primary. 2901, Rachel Street East, #23. Montreal, Quebec H1W 4A4, CA. Get directions. Cambridge, MA 02142, US. Get directions.Employees: 8

Enobia Pharma - Crunchbase Company Profile & Funding

https://www.crunchbase.com/organization/enobia-pharma

About. Enobia Pharma develops therapies for the treatment of serious genetic bone disorders. Acquired by. Alexion Pharmaceuticals. Montreal, Quebec, Canada. 1001-5000.

Enobia Pharma Company Profile: Acquisition & Investors ...

https://pitchbook.com/profiles/company/52644-07

Enobia Pharma General Information Description. Developer of therapies to treat genetic bone disorders for which there are no approved treatments. The company's products are used for the treatment of hypophosphatasia (HPP).

Enobia Pharma LinkedIn

https://ca.linkedin.com/company/enobia-pharma

Enobia Pharma 1,319 followers on LinkedIn. Enobia develops therapies to treat serious genetic bone disorders for which there are no approved treatments. Our lead product in development, ENB-0040 (human recombinant tissue non-specific alkaline phosphatase), is a subcutaneous bone-targeted enzyme replacement therapy for the rare disease hyposphostasia.Employees: 8

Protocol - The New England Journal of Medicine

https://www.nejm.org/doi/suppl/10.1056/NEJMoa1106173/suppl_file/nejmoa1106173_protocol.pdf

Enobia Pharma US Enobia Pharma Headquarters 245 First Street, Suite 1809 2901, Rachel Street East, Suite 23 Cambridge, MA 02142 Montreal, QC H1W4A4 Canada

Alexion to acquire Enobia Pharma for $610 ... - CenterWatch

https://www.centerwatch.com/articles/21834

Jan 03, 2012 · January 3, 2012. CenterWatch Staff. Alexion Pharmaceuticals and Enobia Pharma have signed a definitive agreement under which Alexion will acquire 100% of the capital stock of Enobia. Enobia is a private biopharmaceutical company based in Montreal, Canada and Cambridge, Massachusetts, which is focused on the development of therapies to treat patients with ultra-rare and …

Alexion to Acquire Enobia Pharma for Up to $1.08 Billion - WSJ

https://www.wsj.com/articles/SB10001424052970204720204577127020174878512

Dec 28, 2011 · Enobia, which is based in Montreal and Cambridge, Mass., focuses on development of therapies for patients with genetic metabolic bone disorders.

AstraZeneca - Wikipedia

https://en.wikipedia.org/wiki/AstraZeneca

AstraZeneca plc (/ ˌ æ s t r ə ˈ z ɛ n ə k ə /) is a British-Swedish multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England. It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation.

Alexion

https://alexion.com/

Alexion is a global biopharmaceutical company focused on developing life-changing therapies for people living with rare disorders.

Alexion Pharmaceuticals - Wikipedia

https://en.wikipedia.org/wiki/Alexion_Pharmaceuticals

Alexion Pharmaceuticals Inc. is an American pharmaceutical company best known for its development of Soliris, a drug used to treat the rare disorders atypical hemolytic uremic syndrome and paroxysmal nocturnal hemoglobinuria. The company is also involved in immune system research related to autoimmune diseases. It employs around 2,400 people worldwide. In February 2016, the company held the dedication ceremony for its new headquarters …

Have you found Enobia Pharma Headquarters information?

The links above have surely given you a comprehensive answer to all questions about Enobia Pharma Headquarters.

If you are interested in any other information about corporate offices, headquarters, choose the appropriate page.

Have you found Enobia Pharma Headquarters information?

Popular Searches